Josephine G Walker
Biographic Data
| ID | 7446786 |
|---|---|
| NAME | Josephine G Walker |
| GIVEN NAMES | Josephine G |
| FAMILY NAME | Walker |
| SIGNATURE | WALKER J G |
| AFFILIATIONS | Population Health Sciences, University of Bristol, Bristol, UK |
| VERIFIED | No |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 9 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Gender differences in social networks of women and men who inject drugs in Kenya
Hepatitis C virus cascade of care among adults in Sindh province, Pakistan
Pakistan has the largest national burden of hepatitis C virus (HCV) infections (9.8 million). High levels of testing and treatment are needed to achieve HCV elimination, but little data exists on this in Pakistan. A household sero-survey from Sindh province (2019–2020) collected self-reported data from adults on previous HCV testing and treatment, and undertook HCV-antibody (HCV-Ab) testing of participants (2988 children ( 25 years), and adults w…
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya
This study provides strong evidence for the benefits of NSP and OAT on varied HIV outcomes among PWID in Africa
Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, Vietnam
Using RDS surveys and other care settings to scale-up HCV-testing and treatment are cost-effective strategies to reduce HCV incidence among PWID in Vietnam
Cost-effectiveness of Hepatitis C virus self-testing in four settings
Globally, there are approximately 58 million people with chronic hepatitis C virus infection (HCV) but only 20% have been diagnosed. HCV self-testing (HCVST) could reach those who have never been tested and increase uptake of HCV testing services. We compared cost per HCV viraemic diagnosis or cure for HCVST versus facility-based HCV testing services. We used a decision analysis model with a one-year time horizon to examine the key drivers of eco…
Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
INTRODUCTION: Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins Sans Frontières (MSF) established a direct-acting antiviral (DAA) treatment programme for people HCV/HIV coinfected in Myanmar. The purpose of our study was to evaluate the real-world cost and cost-effectiveness of this programme, and potential cost-effectiveness if imp…
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs
No prominent works on this page.
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
INTRODUCTION: Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins Sans Frontières (MSF) established a direct-acting antiviral (DAA) treatment programme for people HCV/HIV coinfected in Myanmar. The purpose of our study was to evaluate the real-world cost and cost-effectiveness of this programme, and potential cost-effectiveness if imp…
Cost-effectiveness of Hepatitis C virus self-testing in four settings
Globally, there are approximately 58 million people with chronic hepatitis C virus infection (HCV) but only 20% have been diagnosed. HCV self-testing (HCVST) could reach those who have never been tested and increase uptake of HCV testing services. We compared cost per HCV viraemic diagnosis or cure for HCVST versus facility-based HCV testing services. We used a decision analysis model with a one-year time horizon to examine the key drivers of eco…
Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya
Hepatitis C virus cascade of care among adults in Sindh province, Pakistan
Pakistan has the largest national burden of hepatitis C virus (HCV) infections (9.8 million). High levels of testing and treatment are needed to achieve HCV elimination, but little data exists on this in Pakistan. A household sero-survey from Sindh province (2019–2020) collected self-reported data from adults on previous HCV testing and treatment, and undertook HCV-antibody (HCV-Ab) testing of participants (2988 children ( 25 years), and adults w…
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya
This study provides strong evidence for the benefits of NSP and OAT on varied HIV outcomes among PWID in Africa
Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, Vietnam
Using RDS surveys and other care settings to scale-up HCV-testing and treatment are cost-effective strategies to reduce HCV incidence among PWID in Vietnam
Gender differences in social networks of women and men who inject drugs in Kenya
Hepatitis C virus research (6 works) · Medicine (6 works) · Environmental health (5 works) · HIV, Drug Use, Sexual Risk (5 works) · Hepatitis B Virus Studies (4 works) · Hepatitis C (4 works) · Psychological intervention (4 works) · Virology (4 works) · Hepatitis C virus (3 works) · HIV/AIDS Research and Interventions (3 works)